IGM Biosciences, Inc. - COM (IGMS)

Historical Portfolio Holders from Q3 2019 to Q2 2024

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q2	500	$3 K	-$733			$6.00	1
2024 Q1	22.8 M	$220 M	+$9.97 M	49.2 K	107 K	$9.65	84
2023 Q4	21.9 M	$182 M	-$5.06 M	30.7 K	181 K	$8.31	70
2023 Q3	22.3 M	$186 M	+$4.17 M	9.19 K	99.4 K	$8.35	77
2023 Q2	21.8 M	$201 M	+$35.1 M	166 K	204 K	$9.23	77
2023 Q1	17.9 M	$245 M	-$2.26 M	82.4 K	907 K	$13.74	76
2022 Q4	18 M	$306 M	-$109 K	162 K	1.05 M	$17.01	78
2022 Q3	16.8 M	$383 M	-$7.91 M	650 K	1.45 M	$22.74	87
2022 Q2	17.5 M	$315 M	-$25.3 M	252 K	1.95 M	$18.03	89
2022 Q1	17.4 M	$465 M	+$11.1 M	5.53 M	7.82 M	$26.73	89
2021 Q4	17 M	$497 M	+$6.57 M	704 K	959 K	$29.33	82
2021 Q3	16.9 M	$1.11 B	+$20 M	2.82 M	18.1 M	$65.76	101
2021 Q2	16.3 M	$1.36 B	-$128 M	2.88 M	4.27 M	$83.20	104
2021 Q1	18 M	$1.38 B	+$60.8 M	24.2 M	7.06 M	$76.69	108
2020 Q4	17.2 M	$1.51 B	+$224 M	30.6 M	5.31 M	$88.29	107
2020 Q3	14.5 M	$1.07 B	+$48.3 M	41 M	37 M	$73.81	91
2020 Q2	13.9 M	$1.01 B	+$45.8 M			$73.00	78
2020 Q1	13.3 M	$742 M	+$66.8 M			$56.15	60
2019 Q4	12.2 M	$463 M	+$92.4 M			$38.16	50
2019 Q3	10 M	$178 M	+$178 M			$17.75	33